Results
74,196 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Lane NathanDirector |  LPSNLIVEPERSON INCDisposition to issuer | D | — 23.4K sh | Sep 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Lane NathanDirector | LPSNLIVEPERSON INC Disposition to issuer | D | — 23.4K sh | Sep 4, 2026 |
| 9 | Kempster ThomasDirector |  DTSTData Storage CorpOption exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Pace Philip JSVP, Chief Accounting Officer |  BLMNBloomin' Brands, Inc.Option exercise | M | — 15.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Estrampes CatherineChief Commer. & Growth Officer |  GEHCGE HealthCare Technologies Inc.Tax withholding | F | $36K 508 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 9 | Stallone NancyDirector | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Elze ChristianDirector |  PLXProtalix BioTherapeutics, Inc.Grant or award | A | — 17.0K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 9 | Blumenthal Neil HarrisDirector, Co-Chief Executive Officer |  WRBYWarby Parker Inc.Option exercise | M | — 44.6K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Fletcher DanDirector | LPSNLIVEPERSON INC Disposition to issuer | D | — 18.7K sh | Sep 4, 2026 traded Sep 4, 2026 |
| 9 | Lefferts KellyEVP, Chief Legal Officer | BLMNBloomin' Brands, Inc. Option exercise | M | — 15.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Mitchell Uwayne A.Director | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Gosk Kimberly ShannonEVP & CPO |  OTISOtis Worldwide CorpTax withholding | F | $19K 274 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Grover MatthewDirector | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Villanova PatrickChief Financial Officer |  BLBLACKLINE, INC.Option exercise | M | $11K 750 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Ware J. AnthonyDirector |  TRAXFirst Tracks Biotherapeutics, Inc.Option exercise | M | — 28.6K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Bashan DrorDirector, PRESIDENT AND CEO | PLXProtalix BioTherapeutics, Inc. Grant or award | A | — 320.0K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 9 | Lefferts KellyEVP, Chief Legal Officer | BLMNBloomin' Brands, Inc. Tax withholding | F | $37K 3,747 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Bashan DrorDirector, PRESIDENT AND CEO | PLXProtalix BioTherapeutics, Inc. Grant or award | A | — 160.0K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 9 | Brown Christopher D.Director |  MASS908 Devices Inc.Open-market sale · 10b5-1 plan | SELL | $317K 30.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Grover MatthewDirector | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Maglione Lawrence A.Director | DTSTData Storage Corp Option exercise | M | — 10.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 9 | Elze ChristianDirector | PLXProtalix BioTherapeutics, Inc. Grant or award | A | — 8,500 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 8 | Fordyce MarshallDirector, PRESIDENT AND CEO |  VERAVera Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $650K 18.5K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 8 | Christel Eric CEVP, Chief Financial Officer | BLMNBloomin' Brands, Inc. Tax withholding | F | $61K 6,125 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 8 | Vassil JonathanChief Revenue Officer |  TOSTToast, Inc.Open-market sale · 10b5-1 plan | SELL | $171K 5,100 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 8 | Leite JohnGlobal Chief Commercial Off |  VCYTVERACYTE, INC.Tax withholding | F | $178K 3,961 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 7 | Gallagher Thomas P.Director, Chairman & CEO |  MIAXMIAMI INTERNATIONAL HOLDINGS, INC.Option exercise · 10b5-1 plan | M | — 4,464 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 7 | Tighe BrettChief Financial Officer |  OKTAOkta, Inc.Derivative conversion · 10b5-1 plan | C | — 41.3K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 7 | Tang StanleyDirector |  DASHDoorDash, Inc.Other acquisition or disposition · 10b5-1 plan | J | — 30.8K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 6 | McGuire AnnieEVP, General Counsel | VCYTVERACYTE, INC. Open-market sale · 10b5-1 plan | SELL | $92K 2,154 sh | Sep 4, 2026 traded Sep 4, 2026 |
| 5 | Sabino Anthony JohnDirector, Chief Executive Officer | LPSNLIVEPERSON INC Disposition to issuer | D | — 66.7K sh | Sep 4, 2026 traded Sep 4, 2026 |
| 5 | Spanos MikeDirector |  CASYCASEYS GENERAL STORES INCOption exercise | M | — 326 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 5 | Moore Kathryn ASVP, HUMAN RESOURCES |  MSIMotorola Solutions, Inc.Tax withholding | F | $18K 38 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 5 | Comly Barbara J.EVP, GC & Corporate Secretary | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Option exercise · 10b5-1 plan | M | $533K 44.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 5 | Mina Christopher AllenChief Tech Product Officer | LPSNLIVEPERSON INC Disposition to issuer | D | — 43.0K sh | Sep 4, 2026 traded Sep 4, 2026 |
| 5 | Flees Lori AnnDirector, President & CEO |  VVVVALVOLINE INCGrant or award | A | $951 30 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 5 | Spanos MikeDirector | CASYCASEYS GENERAL STORES INC Grant or award | A | — 220 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 5 | Blumenthal Neil HarrisDirector, Co-Chief Executive Officer | WRBYWarby Parker Inc. Option exercise | M | — 44.6K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 5 | Sabino Anthony JohnDirector, Chief Executive Officer | LPSNLIVEPERSON INC Disposition to issuer | D | — 135.3K sh | Sep 4, 2026 traded Sep 4, 2026 |
| 5 | Spetzler David BaxleyPresident |  CAICaris Life Sciences, Inc.Option exercise | M | — 250.0K sh | Sep 4, 2026 traded Sep 4, 2026 |
| 5 | Spetzler David BaxleyPresident | CAICaris Life Sciences, Inc. Option exercise | M | — 1.00M sh | Sep 4, 2026 traded Sep 3, 2026 |